The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
The funding will accelerate Sinopia’s data-driven drug discovery efforts
The company plans to use the newly secured funding to expand the indications of its Grabody platform into high-unmet-need areas
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Growing patent filings and tier-2 innovators reflect expanding national research base
Subscribe To Our Newsletter & Stay Updated
